Form 4 for NSPR InspireMD, Inc.
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-17 · accession 0001493152-23-018325 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-19 | 2023-05-17 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +522.6K | 641.2K | +440% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +174.2K | 220.3K | +378% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | A | A | 522,580 | $0.00 | 641,219 | D | — | — | (F1) These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. |
| 2 | Derivative | Options to purchase common stock (right to buy) | 2023-05-17 | A | A | 174,190 | $0.00 | 220,270 | D | $1.76 · — to 2033-05-17 | 174,190 Common Stock | (F2) The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. |